TrialInternational journal of hematology2026

Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 study.

Hiroyuki Takahashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.